What is the serial number for SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION)?

The USPTO serial number for SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) is 77864191.

What is the registration number for SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION)?

SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) is registered under USPTO registration number 0.

SUB

USPTO Trademark Record

ABANDONED

SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION)

Q: Who owns the SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) trademark?

The SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) trademark is owned by Baxter International Inc..

Q: What class is the SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) trademark registered in?

The SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

SN 77864191·Reg 0·Filed Nov 03, 2009

Owner Baxter International Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) (Serial No. 77864191), Registration No. 0, is a abandoned US trademark filed on Nov 03, 2009 by Baxter International Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION) (Reg. #0) is an abandoned US trademark that was filed in 2009 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 03, 2009

SERIAL

77864191

REG#

Owner

Applicant

Baxter International Inc.

Entity

Corporation

State

Address

One Baxter Parkway, Deerfield, IL, 60015

Country

Attorney

NameLaurel V. Dineff

Law firm

LAUREL V. DINEFF DINEFF TRADEMARK LAW LIMITED

Address

160 N WACKER DR, CHICAGO, IL 60606-1633, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateNov 03, 2009

Serial Number77864191

Registration No.0

Status DateJun 27, 2011

Published for OppositionMar 30, 2010

Mark TypeDesign with words

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2009

YEARS AGO

17y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

24 events

ABANDONMENT - NO USE STATEMENT FILED

Jun 27, 2011

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Jun 27, 2011

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 28, 2010

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 24, 2010

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Sep 24, 2010

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Sep 24, 2010

SOU EXTENSION 1 GRANTED

NOA MAILED - SOU REQUIRED FROM APPLICANT

May 25, 2010

NOA MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 30, 2010

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 30, 2010

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

ASSIGNED TO LIE

Feb 23, 2010

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 23, 2010

LAW OFFICE PUBLICATION REVIEW COMPLETED

EXAMINERS AMENDMENT -WRITTEN

Jan 27, 2010

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jan 27, 2010

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 27, 2010

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jan 27, 2010

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 27, 2010

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Jan 27, 2010

PREVIOUS ALLOWANCE COUNT WITHDRAWN

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 27, 2010

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jan 22, 2010

ASSIGNED TO EXAMINER

TEAS VOLUNTARY AMENDMENT RECEIVED

Nov 13, 2009

TEAS VOLUNTARY AMENDMENT RECEIVED

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

Nov 13, 2009

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

NOTICE OF DESIGN SEARCH CODE MAILED

Nov 11, 2009

NOTICE OF DESIGN SEARCH CODE MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 10, 2009

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 06, 2009

NEW APPLICATION ENTERED

SUBQ HYLENEX RECOMBINANT (HYALURONIDASE HUMAN INJECTION)

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Baxter International Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Laurel V. Dineff

Resources

Company